According to Health Ministry spokeswoman Sima Sadat Lari, 7,640 new cases of infection with the coronavirus were found over the past 24 hours, and 796 of them have been hospitalized, IRNA reported.
The total number of people tested positive for COVID-19 infection in Iran surpassed 1,481,396 following the detection of 7,640 news cases in a 24-hour period, the spokeswoman added.
Lari noted that 1,266,518 patients out of the total 1,481,396 infected people have recovered or been discharged from hospitals.
Some 3,762 other COVID-19 patients are in critical condition and being treated in intensive care units, Lari added.
She said that 9,779,202 tests have so far been carried nationwide.
Earlier in the day, Iran started vaccinations against the deadly virus using the Russian Sputnik V vaccines.
The son of the county’s Health Minister Saeed Namaki, was the first one who received the first jab, Mehr News Agency reported.
According to the Health Ministry, at the first phase of the COVID-19 vaccination, health workers and ICU personnel are being vaccinated while the next receivers of the anti-COVID vaccines will be the elderly and those with disabilities.
It added that 1.3 million Iranians will be vaccinated against the deadly virus by the end of the current [Iranian calendar] year (March 19).
Iran has bought the Sputnik V vaccines from Russia and plans its joint production. The first batch of the Russian vaccine arrived in Iran last week.
Sputnik-V has proven efficient in curing the potentially fatal respiratory disease in 91.6 percent of the cases.
The Islamic Republic is further examining sourcing vaccines from other producers such as India and China.
Iran has purchased 16.8 million doses of COVID-19 vaccines from COVAX, a multi-agency group dedicated to assuring fair access to vaccines for low- and middle-income countries.
Moreover, according to the director of Headquarters for Executing the Order of Imam Khomeini, Iran will produce 14 million doses of a homegrown vaccine before summer.
“We will put into operation the country’s biggest vaccine production line in spring,” Mohammad Mokhber said earlier on Tuesday.
He added that in the first phase, two to three million doses of the COVID-19 vaccines will be produced in the country before the end of the current Iranian calendar year in March and the second phase will focus on the production of 12-14 million doses before summer.